Journal profile · MEDICAL LABORATORY TECHNOLOGY
Advances in Laboratory Medicine-Avances en Medicina de Laboratorio
ISSN 2628-491X · De Gruyter · Germany
Advances in Laboratory Medicine-Avances en Medicina de Laboratorio: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.4 (journal website); diamond open access (no APC); no APC; median 106 days to acceptance (92 articles, last 24 months); 80 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Advances in Laboratory Medicine-Avances en Medicina de Laboratorio is published by De Gruyter and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Clinical Laboratory Practices and Quality Control, COVID-19 Clinical Research Studies and SARS-CoV-2 and COVID-19 Research, together about 36.7% of its articles. Its main subfields are Infectious Diseases. (generated from OpenAlex topic counts and CAS ranking data)
About this journal Objective: Advances in Laboratory Medicine / Avances en Medicina de Laboratorio (Adv Lab Med) is the official journal of the Spanish Society of Laboratory Medicine (SEMEDLAB). Adv Lab Med publishes contributions in the field of medical sciences, including Biochemistry, Hematology, Toxicology, Microbiology and Parasitology, Immunology, and Genetics. Articles focusing on the choice, performance or interpretation of clinical tests are especially welcome. Adv Lab Med is published quarterly. All contributions submitted for publication in Adv Lab Med are subject to single-anonymized peer review by at least two experts in the field, selected and invited by the Editor-in-Chief and a dedicated editorial team. Adv Lab Med publishes only English-language articles.Adv Lab Med is an Open Access journal with an international board of renowned editors. Authors are not charged for manus cript processing and Open Access publication. SEMEDLAB covers processing and publication charges. The Society plays no role in the selection and publication of the articles, nor does it influence peer review.Submissions in the following fields are welcome:Clinical Chemistry / Clinical Hematology and Coagulation / Genetic and Molecular Biology / Clinical Immunology and Autoimmunity / Clinical Microbiology and Parasitology / Drug Monitoring and Toxicology / Evaluation of Diagnostic Biomarkers / New Technologies and Methodologies / Reference Materials and Methods / Reference Values and Decision Limits / Quality Control / Translational Laboratory Medicine / Endocrinology and Metabolism / Lipids and Lipoproteins / Cardiovascular Risk Factors / Cancer Biomarkers / Clinical Metrology / Laboratory Management / POCTArticle FormatsResearch Articles: full length articles and short communications / Reviews and Mini Reviews* / Opinion Papers / Editorials / Lette rs to the Editor and Replies / Case Reports / Guidelines and Recommendations *Adv Lab Med accepts only invited review articles or unsolicited review articles written by authors with extensive experience in the field, as evidenced by at least 10 original articles.Useful linksInstructions for AuthorsSubmission ChecklistTemplate for Ethical and Legal DeclarationsManuscript Preparation and Manuscript TemplatesSpanish Society of Laboratory Medicine (SEMEDLAB)Resources for AuthorsAuthor Language ServiceData Sharing PolicyRights and Permissions Your Benefits Latest developments in the clinical laboratory sciencesFundamental and appl
From the journal's Aims & Scope
Research area (LetPub): MEDICAL LABORATORY TECHNOLOGY
Editor-in-chief Wladimiro Jiménez PovedanoPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Clinical Laboratory Practices and Quality ControlMedicine25.1%
- COVID-19 Clinical Research StudiesMedicine6.6%
- SARS-CoV-2 and COVID-19 ResearchMedicine5%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology4.8%
- Biosimilars and Bioanalytical MethodsImmunology and Microbiology4.8%
- Meta-analysis and systematic reviewsDecision Sciences4.6%
- Prenatal Screening and DiagnosticsMedicine3.6%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine3.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medical Laboratory Technology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medical Laboratory Technology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EBSCO, ProQuest, Baidu, OCLCPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 1.4Publisher website ·
- 5-year impact factor (publisher)
- 2.1Publisher website ·
- CiteScore 2026-06
- 1.7LetPub ·
- CiteScore (publisher)
- 1.7Publisher website ·
- SJR 2026-06
- 0.33LetPub ·
- SNIP 2026-06
- 0.51LetPub ·
- h-index
- 15OpenAlex ·
- i10-index
- 28OpenAlex ·
- 2-year mean citedness
- 0.57OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 56LetPub ·
Articles by year OpenAlex count · 488 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 34 | 34 | 2 |
| 2025 | 80 | 80 | 51 |
| 2024 | 69 | 69 | 51 |
| 2023 | 80 | 80 | 183 |
| 2022 | 65 | 65 | 258 |
| 2021 | 75 | 75 | 367 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
106 daysMedian, submission to acceptance · P25–P75 53 days – 164 days
- Acceptance to online
- median 53 days (92 articles)
- Submission to online
- median 167 days
- Sample
- 92 articles with submission and acceptance dates (130 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 10 weeksLetPub ·
- Submission to publication (journal-reported)
- about 10 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY | |
| OpenAlex | EUR 0 | — | — | |
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- De Gruyter
- Country or region
- Germany
- Language
- English, Spanish
- ISSN
- 2628-491X
- Society / sponsor
- Spanish Society of Laboratory Medicine SEMEDLAB
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Advances in Laboratory Medicine-Avances en Medicina de Laboratorio
What CAS zone is Advances in Laboratory Medicine-Avances en Medicina de Laboratorio in?
In the 2025 upgraded edition of the CAS Journal Ranking, Advances in Laboratory Medicine-Avances en Medicina de Laboratorio is in Zone 4 of Medicine, and in Zone 4 of the minor category Medical Laboratory Technology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Advances in Laboratory Medicine-Avances en Medicina de Laboratorio?
The journal's website gives an impact factor of 1.4; this is the journal's own figure, as LetPub lists none for it; CiteScore 1.7, h-index 15.
How long does peer review take at Advances in Laboratory Medicine-Avances en Medicina de Laboratorio?
Based on the dates recorded on 92 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 106 days (interquartile range 53–164 days); authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Advances in Laboratory Medicine-Avances en Medicina de Laboratorio?
According to LetPub and DOAJ records, Advances in Laboratory Medicine-Avances en Medicina de Laboratorio is indexed in ESCI, Scopus and DOAJ.
Is Advances in Laboratory Medicine-Avances en Medicina de Laboratorio open access, and what is the APC?
Advances in Laboratory Medicine-Avances en Medicina de Laboratorio is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .